155 related articles for article (PubMed ID: 31931737)
1. Approaching treatment for immunological rejection of living-donor liver transplantation in rats.
Feng Y; Han Z; Feng Z; Wang B; Cheng H; Yang L; Li Y; Gu B; Li X; Li Y; Li Y; Wang C; Chen H
BMC Gastroenterol; 2020 Jan; 20(1):7. PubMed ID: 31931737
[TBL] [Abstract][Full Text] [Related]
2. Induction of rejection after small-for-size liver transplantation: size matters.
Dirsch O; Li J; He Q; Ji Y; Gu YL; Dahmen U
J Invest Surg; 2008; 21(5):288-98. PubMed ID: 19160137
[TBL] [Abstract][Full Text] [Related]
3. Impact of donor gender on male rat recipients of small-for-size liver grafts.
Gu Y; Dirsch O; Dahmen U; Ji Y; He Q; Chi H; Broelsch CE
Liver Transpl; 2005 Jun; 11(6):669-78. PubMed ID: 15915489
[TBL] [Abstract][Full Text] [Related]
4. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.
Levay-Young B; Gruessner SE; Shearer JD; Cheol Kim S; Nahkleh RE; Gruessner RW
J Surg Res; 2003 Sep; 114(1):78-89. PubMed ID: 13678702
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts.
Liu F; Li Y; Lan X; Wei YG; Li B; Yan LN; Wen TF; Zhao JC; Xu MQ; Wang WT; Yang JY
World J Gastroenterol; 2009 Aug; 15(31):3931-6. PubMed ID: 19701975
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
7. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome.
Botha JF; Langnas AN; Campos BD; Grant WJ; Freise CE; Ascher NL; Mercer DF; Roberts JP
Liver Transpl; 2010 May; 16(5):649-57. PubMed ID: 20440774
[TBL] [Abstract][Full Text] [Related]
8. Immunologic benefits of longer graft in rat allogenic small bowel transplantation.
Fujishiro J; Tahara K; Inoue S; Kaneko T; Kaneko M; Hashizume K; Kobayashi E
Transplantation; 2005 Jan; 79(2):190-5. PubMed ID: 15665767
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
[TBL] [Abstract][Full Text] [Related]
10. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
[TBL] [Abstract][Full Text] [Related]
12. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts.
Chen PX; Yan LN; Wang WT
World J Gastroenterol; 2014 Jan; 20(1):282-9. PubMed ID: 24415883
[TBL] [Abstract][Full Text] [Related]
14. Effects of intrahepatic arterial and intraportal administration of FK 506 on liver allograft survival in rats.
Yano K; Fukuda Y; Sumimoto R; Ito H; Sumimoto K; Dohi K
Transpl Int; 1994; 7 Suppl 1():S187-93. PubMed ID: 11271200
[TBL] [Abstract][Full Text] [Related]
15. Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience.
Choudhary NS; Saraf N; Saigal S; Gautam D; Rastogi A; Goja S; Bhangui P; Srinivasan T; Yadav SK; Soin A
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29160909
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts.
Misao T; Udaka T; Aoe M; Date H; Andou A; Shimizu N
J Heart Lung Transplant; 1997 Nov; 16(11):1099-105. PubMed ID: 9402508
[TBL] [Abstract][Full Text] [Related]
17. A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy.
Hanaoka K; Kawato Y; Kubo K; Nakanishi T; Maeda M; Nakamura K; Hirose J; Noto T; Fukahori H; Fujikawa A; Miyoshi S; Takakura S; Morokata T; Higashi Y
Transpl Immunol; 2016 Sep; 38():19-26. PubMed ID: 27545900
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
19. An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
Cacciarelli TV; Dvorchik I; Mazariegos GV; Gerber D; Jain AB; Fung JJ; Reyes J
Transplantation; 1999 Sep; 68(5):650-5. PubMed ID: 10507484
[TBL] [Abstract][Full Text] [Related]
20. Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection.
Lasmar MF; Dutra RS; Nogueira-Machado JA; Fabreti-Oliveira RA; Siqueira RG; Nascimento E
BMC Nephrol; 2019 Aug; 20(1):314. PubMed ID: 31409321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
